FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Journal of virology2018; 92(8); e02150-17; doi: 10.1128/JVI.02150-17

Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo.

Abstract: The equine infectious anemia virus (EIAV) attenuated vaccine was developed by long-term passaging of a field-isolated virulent strain in cross-species hosts, followed by successive cultivation in cells To explore the molecular mechanism underlying the evolution of the EIAV attenuated vaccine, a systematic study focusing on long-terminal-repeat (LTR) variation in numerous virus strains ranging from virulent EIAV to attenuated EIAV was performed over time both and Two hypervariable regions were identified within the U3 region in the enhancer region (EHR) and the negative regulatory element (NRE) and within the R region in the transcription start site (TSS) and the Tat-activating region (TAR). Among these sites, variation in the U3 region resulted in the formation of additional transcription factor binding sites; this variation of the -adapted strains was consistent with the loss of pathogenicity. Notably, the same LTR variation pattern was observed both and Generally, the LTR variation in both the attenuated virus and the virulent strain fluctuated over time Interestingly, the attenuated-virus-specific LTR variation was also detected in horses infected with the virulent strain, supporting the hypothesis that the evolution of an attenuated virus might have involved branching from EIAV quasispecies. This hypothesis was verified by phylogenetic analysis. The present systematic study examining the molecular evolution of attenuated EIAV from EIAV quasispecies may provide an informative model reflecting the evolution of similar lentiviruses. The attenuated EIAV vaccine was the first lentiviral vaccine used to successfully control for equine infectious anemia in China. This vaccine provides an important reference for studying the relationship between EIAV gene variation and changes in biological characteristics. Importantly, the vaccine provides a model for the investigation of lentiviral quasispecies evolution. This study followed the "natural" development of the attenuated EIAV vaccine by use of a systematic analysis of LTR evolution and The results revealed that the increase in LTR variation with passaging was accompanied by a decrease in virulence, which indicated that LTR variability might parallel the attenuation of virulence. Interestingly, the attenuated-virus-specific LTR variation was also detected in virulent-strain-infected horses, a finding consistent with those of previous investigations of and evolution. Therefore, we present a hypothesis that the evolution of the attenuated virus may involve branching from EIAV quasispecies present .
Copyright © 2018 Wang et al.
Get Full Text
Publication Date: 2018-03-28 PubMed ID: 29386282PubMed Central: PMC5874411DOI: 10.1128/JVI.02150-17Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the molecular changes over time that occur in the equine infectious anemia virus (EIAV), leading to the development of an attenuated vaccine. The study identifies areas of significant variation in the virus and suggests that this variation might be linked to the loss of pathogenicity and the evolution of the vaccine.

Study Method and Findings

  • In this study, the scientists carried out a systematic analysis of the long-terminal-repeat (LTR) variation in several strains of EIAV. These strains ranged from virulent (disease-causing) to attenuated (weakened).
  • The research identified two regions within the LTR section of the virus, namely the enhancer region (EHR) and negative regulatory element (NRE) in the U3 region, and the transcription start site (TSS) and Tat-activating region (TAR) in the R region, that were highly variable.
  • This variation in the U3 region led to the formation of extra sites for transcription factor binding—proteins that control the rate of transcription of genetic information from DNA to messenger RNA. This was consistent in cell-adapted strains of the virus and matched with the loss of pathogenicity, suggesting that these changes might be responsible for the virus’s transition from virulent to attenuated.

Link to Attenuated Vaccine

  • Importantly, the research found that the pattern of LTR variation observed in cell-cultured viruses was also present in viruses drawn directly from infected horses. This was true for both the virulent and attenuated versions of the virus.
  • This suggests that the changes identified may have played a role in the evolution of the attenuated EIAV vaccine, a vaccine developed through long-term passage of a virulent EIAV strain in cross-species hosts. The evolution likely involved branching from the EIAV ‘quasispecies’—a group of viruses related through a similar mutation or mutations.

Broader Significance

  • The implications of this research extend beyond EIAV alone. As EIAV is a lentivirus—a group of viruses that includes HIV—understanding the variances in its genes and the relationship with changes in its biological characteristics could provide useful insights into the evolution of similar viruses and their potential vaccines.

Cite This Article

APA
Wang XF, Liu Q, Wang YH, Wang S, Chen J, Lin YZ, Ma J, Zhou JH, Wang X. (2018). Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo. J Virol, 92(8), e02150-17. https://doi.org/10.1128/JVI.02150-17

Publication

Journal of virology
ISSN: 1098-5514
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 92
Issue: 8
PII: e02150-17

Researcher Affiliations

Wang, Xue-Feng
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Liu, Qiang
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Wang, Yu-Hong
  • Department of Geriatrics and Gerontology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Wang, Shuai
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Chen, Jie
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Lin, Yue-Zhi
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Ma, Jian
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Zhou, Jian-Hua
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China.
Wang, Xiaojun
  • State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, Harbin, China wangxiaojun@caas.cn.

MeSH Terms

  • Animals
  • Equine Infectious Anemia / genetics
  • Equine Infectious Anemia / metabolism
  • Evolution, Molecular
  • Horses
  • Infectious Anemia Virus, Equine / genetics
  • Infectious Anemia Virus, Equine / metabolism
  • Terminal Repeat Sequences

References

This article includes 38 references
  1. Craigo JK, Montelaro RC. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.. Viruses 2013 Dec 2;5(12):2963-76.
    doi: 10.3390/v5122963pmc: PMC3967156pubmed: 24316675google scholar: lookup
  2. Wang XF, Lin YZ, Li Q, Liu Q, Zhao WW, Du C, Chen J, Wang X, Zhou JH. Genetic Evolution during the development of an attenuated EIAV vaccine.. Retrovirology 2016 Feb 3;13:9.
    doi: 10.1186/s12977-016-0240-6pmc: PMC4738788pubmed: 26842878google scholar: lookup
  3. Payne SL, Fuller FJ. Virulence determinants of equine infectious anemia virus.. Curr HIV Res 2010 Jan;8(1):66-72.
    doi: 10.2174/157016210790416352pubmed: 20210781google scholar: lookup
  4. Cook RF, Leroux C, Issel CJ. Equine infectious anemia and equine infectious anemia virus in 2013: a review.. Vet Microbiol 2013 Nov 29;167(1-2):181-204.
    doi: 10.1016/j.vetmic.2013.09.031pubmed: 24183747google scholar: lookup
  5. Frech K, Brack-Werner R, Werner T. Common modular structure of lentivirus LTRs.. Virology 1996 Oct 1;224(1):256-67.
    doi: 10.1006/viro.1996.0527pubmed: 8862420google scholar: lookup
  6. Carpenter S, Chesebro B. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.. J Virol 1989 Jun;63(6):2492-6.
    pmc: PMC250709pubmed: 2470916doi: 10.1128/JVI.63.6.2492-2496.1989google scholar: lookup
  7. Carpenter S, Alexandersen S, Long MJ, Perryman S, Chesebro B. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.. J Virol 1991 Mar;65(3):1605-10.
    pmc: PMC239946pubmed: 1847479doi: 10.1128/JVI.65.3.1605-1610.1991google scholar: lookup
  8. Payne SL, Rausch J, Rushlow K, Montelaro RC, Issel C, Flaherty M, Perry S, Sellon D, Fuller F. Characterization of infectious molecular clones of equine infectious anaemia virus.. J Gen Virol 1994 Feb;75 ( Pt 2):425-9.
    doi: 10.1099/0022-1317-75-2-425pubmed: 8113766google scholar: lookup
  9. Zheng YH, Sentsui H, Kono Y, Ikuta K. Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages.. Virus Res 2000 Jun;68(1):93-8.
    doi: 10.1016/S0168-1702(00)00147-7pubmed: 10930666google scholar: lookup
  10. Maury W, Thompson RJ, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.. J Virol 2005 May;79(9):5653-64.
    doi: 10.1128/JVI.79.9.5653-5664.2005pmc: PMC1082720pubmed: 15827180google scholar: lookup
  11. Carvalho M, Derse D. The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.. J Virol 1993 Jul;67(7):3885-90.
    pmc: PMC237754pubmed: 8389910doi: 10.1128/JVI.67.7.3885-3890.1993google scholar: lookup
  12. Hines R, Sorensen BR, Shea MA, Maury W. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.. J Virol 2004 Apr;78(7):3407-18.
    doi: 10.1128/JVI.78.7.3407-3418.2004pmc: PMC371083pubmed: 15016863google scholar: lookup
  13. Carvalho M, Derse D. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.. J Virol 1993 Apr;67(4):2064-74.
    pmc: PMC240285pubmed: 8383228doi: 10.1128/JVI.67.4.2064-2074.1993google scholar: lookup
  14. Maury W, Oaks JL, Bradley S. Equine endothelial cells support productive infection of equine infectious anemia virus.. J Virol 1998 Nov;72(11):9291-7.
    pmc: PMC110349pubmed: 9765477doi: 10.1128/JVI.72.11.9291-9297.1998google scholar: lookup
  15. Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Shen R, Wang F, Kong X, Su Z, Zhou J. Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.. Virus Genes 2010 Aug;41(1):86-98.
    doi: 10.1007/s11262-010-0491-6pubmed: 20526660google scholar: lookup
  16. Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.. Arch Virol 2011 Feb;156(2):353-7.
    doi: 10.1007/s00705-010-0877-8pubmed: 21136127google scholar: lookup
  17. Maury W, Perryman S, Oaks JL, Seid BK, Crawford T, McGuire T, Carpenter S. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.. J Virol 1997 Jul;71(7):4929-37.
    pmc: PMC191723pubmed: 9188555doi: 10.1128/JVI.71.7.4929-4937.1997google scholar: lookup
  18. Reis JK, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies.. Virology 2003 Jun 20;311(1):169-80.
    doi: 10.1016/S0042-6822(03)00168-5pubmed: 12832214google scholar: lookup
  19. Payne SL, Pei XF, Jia B, Fagerness A, Fuller FJ. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.. J Virol 2004 Mar;78(5):2478-85.
    doi: 10.1128/JVI.78.5.2478-2485.2004pmc: PMC369206pubmed: 14963146google scholar: lookup
  20. Domingo E, Martínez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortín J, López-Galindez C, Pérez-Breña P, Villanueva N, Nájera R. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review.. Gene 1985;40(1):1-8.
    doi: 10.1016/0378-1119(85)90017-4pubmed: 3912262google scholar: lookup
  21. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses.. PLoS Pathog 2010 Jul 22;6(7):e1001005.
    doi: 10.1371/journal.ppat.1001005pmc: PMC2908548pubmed: 20661479google scholar: lookup
  22. Domingo E, Martin V, Perales C, Grande-Pérez A, García-Arriaza J, Arias A. Viruses as quasispecies: biological implications.. Curr Top Microbiol Immunol 2006;299:51-82.
    pmc: PMC7120838pubmed: 16568896doi: 10.1007/3-540-26397-7_3google scholar: lookup
  23. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.. Nature 2006 Jan 19;439(7074):344-8.
    doi: 10.1038/nature04388pmc: PMC1569948pubmed: 16327776google scholar: lookup
  24. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings.. J Cell Sci 2004 Dec 1;117(Pt 25):5965-73.
    doi: 10.1242/jcs.01589pubmed: 15564374google scholar: lookup
  25. Lin YZ, Shen RX, Zhu ZY, Deng XL, Cao XZ, Wang XF, Ma J, Jiang CG, Zhao LP, Lv XL, Shao YM, Zhou JH. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.. Antiviral Res 2011 Nov;92(2):292-304.
    doi: 10.1016/j.antiviral.2011.08.016pubmed: 21893100google scholar: lookup
  26. Dong J, Cook FR, Haga T, Horii Y, Norimine J, Misawa N, Goto Y, Zhu W. Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan.. Arch Virol 2014 Dec;159(12):3413-20.
    doi: 10.1007/s00705-014-2206-0pubmed: 25149072google scholar: lookup
  27. Zhou T, Yuan XF, Hou SH, Tu YB, Peng JM, Wen JX, Qiu HJ, Wu DL, Chen HC, Wang XJ, Tong GZ. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.. Virus Res 2007 Sep;128(1-2):58-64.
    doi: 10.1016/j.virusres.2007.04.005pubmed: 17499380google scholar: lookup
  28. Zheng YH, Sentsui H, Sugita M, Nakaya T, Kishi M, Hagiwara K, Inoshima Y, Ishihara C, Kono Y, Lu JL, Ikuta K. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.. Virology 2000 Jan 5;266(1):129-39.
    doi: 10.1006/viro.1999.0076pubmed: 10612667google scholar: lookup
  29. Payne SL, La Celle K, Pei XF, Qi XM, Shao H, Steagall WK, Perry S, Fuller F. Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism.. J Gen Virol 1999 Mar;80 ( Pt 3):755-759.
    doi: 10.1099/0022-1317-80-3-755pubmed: 10092016google scholar: lookup
  30. Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Zhou J. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.. Virus Genes 2011 Apr;42(2):220-8.
    doi: 10.1007/s11262-010-0563-7pubmed: 21369830google scholar: lookup
  31. Wang XF, Wang S, Liu Q, Lin YZ, Du C, Tang YD, Na L, Wang X, Zhou JH. A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.. Viruses 2014 Nov 10;6(11):4265-79.
    doi: 10.3390/v6114265pmc: PMC4246221pubmed: 25390683google scholar: lookup
  32. Wei HM, Wang XF, Wang SS, Du C, Liu HF, Liu Q, Zhou JH. [The application of single-genome amplification and sequencing in genomic analysis of an attenuated EIAV vaccine].. Bing Du Xue Bao 2012 Jun;28(4):431-8.
    pubmed: 22978170
  33. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.. J Exp Med 1997 Feb 17;185(4):621-8.
    doi: 10.1084/jem.185.4.621pmc: PMC2196142pubmed: 9034141google scholar: lookup
  34. van Rij RP, Blaak H, Visser JA, Brouwer M, Rientsma R, Broersen S, de Roda Husman AM, Schuitemaker H. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.. J Clin Invest 2000 Dec;106(12):1569.
    doi: 10.1172/JCI7953C1pmc: PMC381479pubmed: 11120764google scholar: lookup
  35. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.. AIDS Res Hum Retroviruses 2004 Jan;20(1):111-26.
    doi: 10.1089/088922204322749567pubmed: 15000703google scholar: lookup
  36. Ma J, Shi N, Jiang CG, Lin YZ, Wang XF, Wang S, Lv XL, Zhao LP, Shao YM, Kong XG, Zhou JH, Shen RX. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.. Virology 2011 Feb 5;410(1):96-106.
    doi: 10.1016/j.virol.2010.10.032pubmed: 21094511google scholar: lookup
  37. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.. Mol Biol Evol 2013 Dec;30(12):2725-9.
    doi: 10.1093/molbev/mst197pmc: PMC3840312pubmed: 24132122google scholar: lookup
  38. Tang YD, Na L, Zhu CH, Shen N, Yang F, Fu XQ, Wang YH, Fu LH, Wang JY, Lin YZ, Wang XF, Wang X, Zhou JH, Li CY. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.. J Virol 2014 Nov;88(21):12296-310.
    doi: 10.1128/JVI.01379-14pmc: PMC4248950pubmed: 25122784google scholar: lookup

Citations

This article has been cited 9 times.
  1. Wang XF, Wang YH, Bai B, Zhang M, Chen J, Zhang X, Gao M, Wang X. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization. J Virol 2021 Nov 9;95(23):e0108721.
    doi: 10.1128/JVI.01087-21pubmed: 34495693google scholar: lookup
  2. Lin Y, Wang XF, Wang Y, Du C, Ren H, Liu C, Zhu D, Chen J, Na L, Liu D, Yang Z, Wang X. Env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine. Emerg Microbes Infect 2020 Dec;9(1):1309-1320.
    doi: 10.1080/22221751.2020.1773323pubmed: 32525460google scholar: lookup
  3. Malossi CD, Fioratti EG, Cardoso JF, Magro AJ, Kroon EG, Aguiar DM, Borges AMCM, Nogueira MF, Ullmann LS, Araujo JP Jr. High Genomic Variability in Equine Infectious Anemia Virus Obtained from Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case. Viruses 2020 Feb 12;12(2).
    doi: 10.3390/v12020207pubmed: 32059508google scholar: lookup
  4. Du C, Duan Y, Wang XF, Lin Y, Na L, Wang X, Chen K, Wang X. Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis. J Virol 2019 Nov 1;93(21).
    doi: 10.1128/JVI.00653-19pubmed: 31391270google scholar: lookup
  5. Wang XF, Bai B, Lin Y, Qi T, Du C, Song M, Wang X. High-Efficiency Rescue of Equine Infectious Anemia Virus from a CMV-Driven Infectious Clone. Virol Sin 2019 Dec;34(6):725-728.
    doi: 10.1007/s12250-019-00153-wpubmed: 31376080google scholar: lookup
  6. Alnaeem AA, Hemida MG. Surveillance of the equine infectious anemia virus in Eastern and Central Saudi Arabia during 2014-2016. Vet World 2019 May;12(5):719-723.
    doi: 10.14202/vetworld.2019.719-723pubmed: 31327910google scholar: lookup
  7. Liu C, Wang XF, Wang Y, Chen J, Zhong Z, Lin Y, Wang X. Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity. Viruses 2019 Apr 24;11(4).
    doi: 10.3390/v11040380pubmed: 31022927google scholar: lookup
  8. Liang H, Zhou B, Hu Z, Chu X, Wang X, Du C, Wang X. Development of a Broad-Spectrum Antigen-Capture ELISA Using Combined Anti-p26 Polyclonal and Monoclonal Antibodies for Detection of Equine Infectious Anemia Virus. Microorganisms 2025 Jun 27;13(7).
    doi: 10.3390/microorganisms13071500pubmed: 40732013google scholar: lookup
  9. Bai B, Zhang X, Zhang M, Ma W, Li J, Zhang H, Na L, Guo X, Lin Y, Wang XF, Wang X. EIAV encodes an accessory protein that antagonizes the host restriction factor equine tetherin. Proc Natl Acad Sci U S A 2025 Jul;122(26):e2413703122.
    doi: 10.1073/pnas.2413703122pubmed: 40549908google scholar: lookup
Subscribe to our newsletter
Join 100,129 horse owners like you who receive our email updates on horse health and nutrition.